ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Adiponectin, an anti-inflammatory adipokine lowered in plasma in individuals with obesity, is known to have significant anti-inflammatory, anti-atherogenic, anti-apoptotic, and insulin-sensitising properties [1, 2].